Product hub: Environmental monitoring: a critical and challenging requirement
Posted: 29 June 2022 | bioMérieux | No comments yet
Read about bioMérieux’s new system, 3P® ENTERPRISE – an end-to-end solution that fully digitalises and automates the EM process.
Environmental monitoring (EM) is one the main microbiological controls that the biotechnology and pharmaceutical industries perform. The classical method is extremely manual, variable and error-prone, but it remains the standard procedure used in industry for hundreds of millions of samples per year. It is inevitable, with this high number of samples, that errors occur – data integrity failures, incorrect enumerations, missed samples, all leading to time-consuming and expensive investigations which ultimately impact patient safety. As a strategic pillar, to ensure companies maintain compliance, EM must be robust and reliable at every single step.
Related content from this organisation
- European Pharmaceutical Review Issue 4 2024
- Application note: Automated nucleic acid amplification assay for mycoplasma detection in cell and gene therapy products
- Next-Generation Rapid mRNA Vaccine CQA Analytics
- Application note: Role of in-house isolates in pharmaceutical quality control
- Application note: Low Endotoxin Recovery case study
Issue
Related topics
Data integrity, Environmental Monitoring, Microbial Detection